164 related articles for article (PubMed ID: 709550)
1. Biology and therapeutic response of a mouse mammary adenocarcinoma (16/C) and its potential as a model for surgical adjuvant chemotherapy.
Corbett TH; Griswold DP; Roberts BJ; Peckham JC; Schabel FM
Cancer Treat Rep; 1978 Oct; 62(10):1471-88. PubMed ID: 709550
[TBL] [Abstract][Full Text] [Related]
2. Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models.
Schmid FA; Sirotnak FM; Otter GM; DeGraw JI
Cancer Treat Rep; 1987; 71(7-8):727-32. PubMed ID: 3607784
[TBL] [Abstract][Full Text] [Related]
3. Comparison of adjuvant chemotherapeutic activity against primary and metastatic spontaneous murine tumors.
Fugmann RA; Anderson JC; Stolfi RL; Martin DS
Cancer Res; 1977 Feb; 37(2):496-500. PubMed ID: 832274
[TBL] [Abstract][Full Text] [Related]
4. Pre-, peri-, and postoperative chemotherapy for breast cancer: is one better than the other?
Murthy MS; Scanlon EF; Reid SE; Yang XF
J Surg Oncol; 1996 Apr; 61(4):273-7. PubMed ID: 8627997
[TBL] [Abstract][Full Text] [Related]
5. Nitrosoureas: a review of experimental antitumor activity.
Schabel FM
Cancer Treat Rep; 1976 Jun; 60(6):665-98. PubMed ID: 782694
[TBL] [Abstract][Full Text] [Related]
6. Antitumor efficacy of interleukin-2 alone and in combination with adriamycin and dacarbazine in murine solid tumor systems.
LoRusso PM; Aukerman SL; Polin L; Redman BG; Valdivieso M; Biernat L; Corbett TH
Cancer Res; 1990 Sep; 50(18):5876-82. PubMed ID: 2393858
[TBL] [Abstract][Full Text] [Related]
7. Transplantable mouse 16/c mammary adenocarcinoma as a model in experimental cancer therapy. II. Modification of tumor-host interactions by therapeutic procedures.
Rak J; Strzadała L; Kuśnierczyk H; Radzikowski C
Arch Immunol Ther Exp (Warsz); 1989; 37(3-4):379-88. PubMed ID: 2639634
[TBL] [Abstract][Full Text] [Related]
8. Synergistic activity of recombinant human endostatin in combination with adriamycin: analysis of in vitro activity on endothelial cells and in vivo tumor progression in an orthotopic murine mammary carcinoma model.
Plum SM; Hanson AD; Volker KM; Vu HA; Sim BK; Fogler WE; Fortier AH
Clin Cancer Res; 2003 Oct; 9(12):4619-26. PubMed ID: 14555538
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous metastasis from primary C3H mouse mammary tumors.
Vaage J; Harlos JP
Cancer Res; 1987 Jan; 47(2):547-50. PubMed ID: 3791241
[TBL] [Abstract][Full Text] [Related]
10. Transplantable mouse mammary adenocarcinoma 16/c as a model in experimental cancer therapy. III. Sensitivity to antitumor drugs.
Rak J; Kuśnierczyk H; Strzadała L; Kłosiewicz S; Radzikowski C
Arch Immunol Ther Exp (Warsz); 1989; 37(3-4):389-97. PubMed ID: 2639635
[TBL] [Abstract][Full Text] [Related]
11. Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors.
Corbett TH; Griswold DP; Mayo JG; Laster WR; Schabel FM
Cancer Res; 1975 Jun; 35(6):1568-73. PubMed ID: 1131824
[TBL] [Abstract][Full Text] [Related]
12. Distribution of adriamycin in mice under conditions of local hyperthermia which improve systemic drug therapy.
Magin RL; Cysyk RL; Litterst CL
Cancer Treat Rep; 1980; 64(2-3):203-10. PubMed ID: 7407753
[TBL] [Abstract][Full Text] [Related]
13. Comparative study on the effects of surgery, chemotherapy, and immunotherapy, alone and in combination, on metastases of the 13762 mammary adenocarcinoma.
Bogden AE; Esber HJ; Taylor DJ; Gray JH
Cancer Res; 1974 Jul; 34(7):1627-31. PubMed ID: 4857731
[No Abstract] [Full Text] [Related]
14. Can neo-adjuvant chemotherapy prevent residual tumors?
Bourut C; Chenu E; Mathé G
Bull Soc Sci Med Grand Duche Luxemb; 1989; 126(1):59-63. PubMed ID: 2743533
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy with short interfering RNA vectors against VEGF-C and VEGF-A suppresses lymph node and lung metastasis in a mouse immunocompetent mammary cancer model.
Shibata MA; Morimoto J; Shibata E; Otsuki Y
Cancer Gene Ther; 2008 Dec; 15(12):776-86. PubMed ID: 18654613
[TBL] [Abstract][Full Text] [Related]
16. On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testing.
Man S; Munoz R; Kerbel RS
Cancer Metastasis Rev; 2007 Dec; 26(3-4):737-47. PubMed ID: 17846863
[TBL] [Abstract][Full Text] [Related]
17. In vivo surgical resection plus adjuvant gene therapy in the treatment of mammary and prostate cancer.
Sukin SW; Chhikara M; Zhu X; Ayala G; Aguilar LK; O'Brian Smith E; Miles BJ; Thompson TC; Kadmon D; Aguilar-Cordova E
Mol Ther; 2001 Apr; 3(4):500-6. PubMed ID: 11319910
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of menogaril alone, and in combination against human mammary cancer models in mice and rats.
Yoshida M; Fujioka A; Nakano K; Kobunai T; Saito H; Toko T; Takeda S; Unemi N
Anticancer Res; 1996; 16(3A):1155-9. PubMed ID: 8702227
[TBL] [Abstract][Full Text] [Related]
19. Chemoimmunotherapy of murine mammary adenocarcinomas.
Ames IH
Anticancer Res; 2004; 24(4):2249-56. PubMed ID: 15330169
[TBL] [Abstract][Full Text] [Related]
20. Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen with leucovorin rescue against metastatic murine solid tumors.
Sirotnak FM; Otter GM; Schmid FA
Cancer Res; 1993 Feb; 53(3):587-91. PubMed ID: 8425192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
